Poland· PL-100462100
Betaxolol Medreg
A betaxolol product containing betaxololi hydrochloridum, registered in Poland by Medreg s.r.o.. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Betaxolol is registered in 8 of 19 countries.
Countries holding a registration under ATC C07AB05 (betaxolol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Betaxolol · ATC C07AB05
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Finlandprice
- Germany
- Japan
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Betaxololi hydrochloridum
- Manufacturer
- Medreg s.r.o.
- Country
- Poland (PL)
- ATC code
- C07AB05
- ATC class
- Betaxolol
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 10
- gtin08595566454852
- gtin08595566454845
- gtin08595566454883
- gtin08595566454869
- gtin08595566454876
- gtin08595566455477
- gtin08595566454890
- gtin08595566454920
- gtin08595566454937
- gtin08595566454913
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
223 interactions on record for betaxolol.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Betaxolol · interactions on record
223 records
- 11 severe
- 184 moderate
- 20 minor
- 8 info
Most severe, free to view
- DolasetronA04AA04severe
- TheophyllinC01EB28severe
- CeritinibL01ED02severe
- CeritinibL01XE28severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Betaxolol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBETAXOLOL MEDREGMEDREG s.r.o., Praha
- United KingdomKerlone 20mg tabletsSanofi-Synthelabo Ltd
- United StatesBetaxololPuraCap Laboratories LLC
- FranceBETAXOLOL BIOGARAN 20 mg, comprimé pelliculé sécableBIOGARAN
- FinlandBetopticImmedica Pharma AB
- BelgiumBetoptic 5 mg/mlNovartis Pharma
- NorwayBetopticImmedica Pharma AB
- SwitzerlandBetoptic S
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Betoptic S
- Belgium · Betoptic, Betoptic S
- Bulgaria · Бетак, Бетоптик S
- Cyprus · Betac
- Czechia · Betamed, Betaxolol Medreg
- Germany · Betoptima, Kerlone
- Denmark · Betoptic S
- Estonia · Betoptic S
- Spain · Betoptic
- Finland · Betoptic, Betoptic S
- France · Betaxolol Biogaran, Betaxolol Eg
- United Kingdom (Northern Ireland) · Betoptic
- Greece · Betoptic, Betoptic S
- Croatia · Betoptic
- Hungary · Betoptic, Lokren
- Italy · Betoptic, Kerlon
- Lithuania · Betac, Betaxolol Pmcs
- Luxembourg · Betoptic, Betoptic S
- Latvia · Betac, Betaxolol Pmcs
- Netherlands · Betoptic S
- Norway · Betoptic, Betoptic S
- Portugal · Bertocil, Betoptic
- Romania · Betaxolol Gemax Pharma, Betoptic S
- Sweden · Betoptic, Betoptic S
- Slovenia · Betoptic, Betoptic S
- Slovakia · Betac, Betaxolol Medreg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/791ec12b-68cf-461b-ad61-e809a3d20550 GET /v1/drugs/791ec12b-68cf-461b-ad61-e809a3d20550?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki",
"source": "urpl",
"strength": "20 mg",
"packaging": "08595566454852 ¦ Rp ¦ 146892\n20 tabl.\n08595566454845 ¦ Rp ¦ 146893\n10 tabl.\n08595566454883 ¦ Rp ¦ 146894\n50 tabl.\n08595566454869 ¦ Rp ¦ 146895\n28 tabl.\n08595566454876 ¦ Rp ¦ 146896\n30 tabl.\n08595566455477 ¦ Rp ¦ 146897\n84 tabl.\n08595566454890 ¦ Rp ¦ 146898\n60 tabl.\n08595566454920 ¦ Rp ¦ 146899\n98 tabl.\n08595566454937 ¦ Rp ¦ 146900\n100 tabl.\n08595566454913 ¦ Rp ¦ 146901\n90 tabl.",
"substance": "Betaxololi hydrochloridum 20 mg",
"common_name": "Betaxololi hydrochloridum",
"pl_product_id": "100462100",
"pozwolenie_nr": "27368",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about betaxolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.